| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10793 | 2021 |
| C3 glomerulopathy: consensus report MC Pickering, VD D'agati, CM Nester, RJ Smith, M Haas, GB Appel, ... Kidney international 84 (6), 1079-1089, 2013 | 709 | 2013 |
| Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome EG de Jorge, CL Harris, J Esparza-Gordillo, L Carreras, EA Arranz, ... Proceedings of the National Academy of Sciences 104 (1), 240-245, 2007 | 544 | 2007 |
| Complement, a target for therapy in inflammatory and degenerative diseases BP Morgan, CL Harris Nature reviews Drug discovery 14 (12), 857-877, 2015 | 442 | 2015 |
| Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59 A Clayton, CL Harris, J Court, MD Mason, BP Morgan European journal of immunology 33 (2), 522-531, 2003 | 362 | 2003 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 324 | 2021 |
| Complement regulatory proteins BP Morgan, AL Harris Academic Press, 1999 | 318 | 1999 |
| Dimerization of complement factor H-related proteins modulates complement activation in vivo E Goicoechea de Jorge, JJE Caesar, TH Malik, M Patel, M Colledge, ... Proceedings of the National Academy of Sciences 110 (12), 4685-4690, 2013 | 307 | 2013 |
| Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation R Martínez-Barricarte, M Heurich, F Valdes-Cañedo, E Vazquez-Martul, ... The Journal of clinical investigation 120 (10), 3702-3712, 2010 | 261 | 2010 |
| Complement: central to innate immunity and bridging to adaptive responses BP Morgan, KJ Marchbank, MP Longhi, CL Harris, AM Gallimore Immunology letters 97 (2), 171-179, 2005 | 259 | 2005 |
| Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy DM Thompson, M Meloche, Z Ao, B Paty, P Keown, RJ Shapiro, S Ho, ... Transplantation 91 (3), 373-378, 2011 | 254 | 2011 |
| Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk M Heurich, R Martínez-Barricarte, NJ Francis, DL Roberts, ... Proceedings of the National Academy of Sciences 108 (21), 8761-8766, 2011 | 251 | 2011 |
| Complement therapeutics; history and current progress BP Morgan, CL Harris Molecular immunology 40 (2-4), 159-170, 2003 | 222 | 2003 |
| C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation A Tortajada, H Yébenes, C Abarrategui-Garrido, J Anter, ... The Journal of clinical investigation 123 (6), 2434-2446, 2013 | 211 | 2013 |
| A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes GL Warnock, DM Thompson, RM Meloche, RJ Shapiro, Z Ao, P Keown, ... Transplantation 86 (12), 1762-1766, 2008 | 197 | 2008 |
| CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells K Elward, M Griffiths, M Mizuno, CL Harris, JW Neal, BP Morgan, ... Journal of Biological Chemistry 280 (43), 36342-36354, 2005 | 196 | 2005 |
| The central role of EED in the orchestration of polycomb group complexes Q Cao, X Wang, M Zhao, R Yang, R Malik, Y Qiao, A Poliakov, AK Yocum, ... Nature communications 5 (1), 3127, 2014 | 188 | 2014 |
| PIG‐M transfers the first mannose to glycosylphosphatidylinositol on the lumenal side of the ER Y Maeda, R Watanabe, CL Harris, Y Hong, K Ohishi, K Kinoshita, ... The EMBO journal, 2001 | 183 | 2001 |
| Structural basis for complement factor I control and its disease-associated sequence polymorphisms P Roversi, S Johnson, JJE Caesar, F McLean, KJ Leath, SA Tsiftsoglou, ... Proceedings of the National Academy of Sciences 108 (31), 12839-12844, 2011 | 165 | 2011 |
| The complotype: dictating risk for inflammation and infection CL Harris, M Heurich, SR de Cordoba, BP Morgan Trends in immunology 33 (10), 513-521, 2012 | 157 | 2012 |
